首页 | 本学科首页   官方微博 | 高级检索  
     

恶性脑胶质瘤术后替莫唑胺化疗联合适形放疗的疗效观察
引用本文:周绍兵 刘阳晨 高飞 叶宏勋 赵莺 尹小祥. 恶性脑胶质瘤术后替莫唑胺化疗联合适形放疗的疗效观察[J]. 陕西肿瘤医学, 2008, 0(1): 34-35
作者姓名:周绍兵 刘阳晨 高飞 叶宏勋 赵莺 尹小祥
作者单位:江苏省泰兴市人民医院放疗科,江苏泰兴225400
摘    要:目的:观察替莫唑胺联合适形放疗治疗恶性脑胶质瘤术后病例的临床疗效。方法:30例恶性脑胶质瘤术后的患者,13例行替莫唑胺联合适形放射治疗(治疗组),另17例单纯适形放射治疗(对照组)。结果:治疗组与对照组的中位生存时期为16.5个月和12.7个月;其1、2年生存率分别为76.9%、46.2%和52.9%、17.6%(P〉0.05)。结论:替莫唑胺联合适形放射治疗恶性脑胶质瘤术后有提高生存率的趋势,并发症少。

关 键 词:恶性胶质瘤  替莫唑胺  三维适形放射治疗
文章编号:1672-4992-(2008)01-0034-02
收稿时间:2007-03-05

Clinical observation of temozlomide with three dimensional conformal radiotherapy in treatment of postoperative malignant glioma
ZHOU Shao - bing, LIU Yang -chen, GAO Fei, YE Hong - xun, ZHAO Ying, YIN Xiao - xiang. Clinical observation of temozlomide with three dimensional conformal radiotherapy in treatment of postoperative malignant glioma[J]. Shaanxi Oncology Medicine, 2008, 0(1): 34-35
Authors:ZHOU Shao - bing   LIU Yang -chen   GAO Fei   YE Hong - xun   ZHAO Ying   YIN Xiao - xiang
Affiliation:ZHOU Shao - bing, LIU Yang -chen, GAO Fei, YE Hong - xun, ZHAO Ying, YIN Xiao - xiang( Department of Radiation Oncology, The People's Hospital of Taixing City,Taixing 225400 ,China.)
Abstract:Objective :To evaluate the treatment efficacy of temozolomide(TMZ) with three dimensional conformal radiotherapy (3DCRT) for postoperative malignant glioma. Methods: Thirty postoperative patients with malignant glioma were randomized into two groups :13 patients received TMZ and 3 DCRT (therapy group) ;17 patients received 3DCRT alone (control group). Results: Median time to progression was 16.5 months in therapy group and 12.7 months in control group. The 1 - and 2 - year survival rates were 76.9% ,46.2% and 52.9% , 17.6% ( P 〉 0.05 ). Conclusion: TMZ and 3DCRT for postoperative malignant glioma can improve the survival rate and decrease complications.
Keywords:malignant glioma   temozolomide   three dimensional conformal radiotherapy
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号